Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Recurrence × Mitomycin × 30 days × Clear all

Sponsor

Conditions

Urinary Bladder Neoplasms 4 Non-Muscle Invasive Bladder Neoplasms 4 Anus Neoplasms 2 Sarcoma 1 Rectal Neoplasms 1 Pseudomyxoma Peritonei 1 Pleural Neoplasms 1 Peritoneal Neoplasms 1 Ovarian Neoplasms 1 Necrosis 1 Mediastinal Neoplasms 1 HIV Infections 1 Gastrointestinal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Appendiceal Neoplasms 1 Anal Canal Carcinoma 1

Interventions

Cyclophosphamide 10 fludarabine 8 Rituximab 8 Dexamethasone 8 pembrolizumab 7 venetoclax 5 glofitamab 5 Lenalidomide 5 obinutuzumab 4 Etoposide 4 Calcium Dobesilate 4 pomalidomide 3 Temozolomide 3 Doxorubicin 3 Cytarabine 3 zanubrutinib 2 tocilizumab 2 tisagenlecleucel 2 selinexor 2 ruxolitinib 2 ibrutinib 2 enzalutamide 2 dexamethasone acetate 2 dexamethasone 21-phosphate 2 carfilzomib 2 abemaciclib 2 Vincristine 2 Surgical Procedures, Operative 2 Radiotherapy 2 Prednisone 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡